LFACX - Overview: Cryptococcus Antigen with Reflex, Spinal Fluid

Aiding in the diagnosis of cryptococcosis This test should not be used as a test of cure or to guide treatment decisions. This test should not be performed as a screening procedure for the general population.

CMAT - Overview: Chromosomal Microarray, Tumor, Fresh or Frozen

Genomic characterization of tumor for copy number imbalances and loss of heterozygosity Assisting in the diagnosis and classification of malignant neoplasms, including hematolymphoid malignancies Evaluating the prognosis for patients with...

CLFA - Overview: Cryptococcus Antigen Screen with Titer, Spinal Fluid

Aiding in the diagnosis of cryptococcosis This test should not be performed as a screening procedure for the general population. This test should not be used as a test of cure or to guide treatment decisions.

CHF8 - Overview: Chromogenic Factor VIII Activity Assay, Plasma

Monitoring coagulation factor replacement therapy of selected extended half-life coagulation factor replacements Aiding in the diagnosis of hemophilia A using a 2-stage assay, especially when the 1-stage assay result was normal

DRVI4 - Overview: Dilute Russell's Viper Venom Time (DRVVT) Interpretation

Interpreting mixing and confirmation assays for lupus anticoagulants

STL - Overview: Enteric Pathogens Culture, Feces

Determining whether a bacterial enteric pathogen is the cause of diarrhea May be helpful in identifying the source of the infectious agent (eg, dairy products, poultry, water, or meat) This test is generally not useful for patients...

HYOX - Overview: Hyperoxaluria Panel, Random, Urine

Distinguishing between primary and secondary hyperoxaluria Distinguishing between primary hyperoxaluria types 1, 2, and 3

HEXLA - Overview: Hexagonal Lupus Anticoagulant, Plasma

Confirming or excluding the presence of a lupus anticoagulant (LA), in conjunction with other appropriate coagulation tests Differentiating between deficiencies or inhibitors of specific coagulation factors and LA inhibitors Evaluating a...

GPSYP - Overview: Glucopsychosine, Plasma

Second-tier test when newborn screening results with reduced beta-glucosidase (GBA) activity are identified Diagnosis and monitoring of patients with Gaucher disease using plasma specimens Supporting a biochemical diagnosis of Gaucher...

MYCO - Overview: Mycoplasma pneumoniae Antibodies, IgG and IgM, Serum

Screening for recent or past exposure to Mycoplasma pneumoniae This test should not be used as a screening procedure for the general population.